Hasandalan, Krystal .
HRN: 23-83-73 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/30/2024
AMPICILLIN 500MG (VIAL)
10/30/2024
11/05/2024
IV
400mg
Q6
Pcap
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes